argus

Eris Lifesciences Limited

NSE: ERISINE406M0102417,963 Cr

Timeline

Time (IST)TypeMEventSrc
20 Feb, 11:41 amEris Lifesciences Limited has informed the Exchange about Transcriptnse
13 Feb, 10:31 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
13 Feb, 10:29 pmEris Lifesciences Limited has informed the Exchange about Link of Recordingnse
13 Feb, 03:20 pmEris Lifesciences Limited has informed the Exchange about Investor Presentationnse
13 Feb, 02:19 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
13 Feb, 01:27 pmEris Lifesciences Ltd - 540596 - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025bse
13 Feb, 01:24 pmEris Lifesciences Limited has informed the Exchange regarding Board meeting held on February 13, 2026.nse
13 Feb, 01:22 pmEris Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
13 Feb, 01:21 pmEris Lifesciences Ltd - 540596 - Board Meeting Outcome for Outcome Of Board Meetingbse
06 Feb, 04:30 pmEris Lifesciences Ltd - 540596 - Board Meeting Intimation for Approval Of Financial Resultsbse
16 Jan, 08:48 pmEris Lifesciences Limited has informed the Exchange regarding allotment of 2306372 securities pursuant to Preferential Issue at its meeting held on January 16, 2026nse
16 Jan, 08:48 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Allotmentbse
18 Dec, 03:51 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Cessationbse
18 Dec, 03:51 pmEris Lifesciences Limited has informed the Exchange regarding Cessation of Rajeev Dalal as Non- Executive Independent Director of the company w.e.f. December 18, 2025.nse
17 Dec, 08:05 pmEris Lifesciences Limited has informed the Exchange regarding 'Second Corrigendum To The Notice Of Postal Ballot Dated November 24, 2025'.nse
10 Dec, 01:59 pmEris Lifesciences Limited has informed the Exchange regarding ' Clarification With Respect To Increase In Volume'.nse
10 Dec, 11:52 amEris Lifesciences Ltd - 540596 - Clarification sought from Eris Lifesciences Ltdbse
05 Dec, 06:32 pmEris Lifesciences Limited has informed the Exchange regarding 'Corrigendum to the Notice of Postal Ballot dated November 24, 2025'.nse
03 Dec, 03:56 pmEris Lifesciences Limited has informed the Exchange regarding 'Corporate Presentation'.nse
24 Nov, 06:40 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Acquisitionbse
24 Nov, 06:34 pmEris Lifesciences Limited has informed the Exchange about issue of Securitiesnse
24 Nov, 06:34 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Issue of Securitiesbse
24 Nov, 06:25 pmEris Lifesciences Limited has informed the Exchange regarding Board meeting held on November 24, 2025.nse
24 Nov, 06:06 pmEris Lifesciences Limited has informed the Exchange regarding Outcome of Board Meeting held on November 24, 2025.nse
19 Nov, 02:43 pmEris Lifesciences Ltd - 540596 - Board Meeting Intimation for Issuance Of Equity Shares Of The Company By Way Of A Preferential Issuebse
14 Nov, 05:24 pmEris Lifesciences Limited has informed the Exchange about Transcriptnse
14 Nov, 05:20 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
12 Nov, 08:03 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
12 Nov, 08:00 pmEris Lifesciences Limited has informed the Exchange about Link of Recordingnse
12 Nov, 06:31 pmEris Lifesciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
12 Nov, 01:46 pmOutcome of Board Meetingnse
12 Nov, 01:45 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
12 Nov, 01:44 pmEris Lifesciences Ltd - 540596 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025bse
12 Nov, 01:41 pmEris Lifesciences Limited has informed the Exchange about Investor Presentationnse
12 Nov, 01:36 pmEris Lifesciences Limited has informed the Exchange regarding Board meeting held on November 12, 2025.nse
06 Nov, 06:58 pmEris Lifesciences Ltd - 540596 - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2025.bse